Are Salt Tablets Effective in the Treatment of Euvolemic Hyponatremia?

被引:5
作者
Spanuchart, Ittikorn [1 ,2 ]
Watanabe, Hideaki [1 ,2 ]
Aldan, Thomas [1 ,2 ]
Chow, Dominic [1 ,2 ]
Ng, Roland C. K. [1 ,2 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA 90095 USA
[2] Univ Hawaii, Dept Med, John A Burns Sch Med, 321 N Kuakini St,407, Honolulu, HI 96817 USA
关键词
hyponatremia; sodium chloride tablets; syndrome of inappropriate antidiuresis; PREVALENCE; DIAGNOSIS; BURDEN;
D O I
10.14423/SMJ.0000000000001075
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives There is limited evidence for the use of salt tablets in the treatment of hyponatremia. This retrospective study evaluated the effectiveness of salt tablet administration in euvolemic hyponatremia. Methods This was a single-center, retrospective cohort study. Information on patients' demographics, clinical characteristics, and laboratory data were collected for retrospective review. Treatment for hyponatremia, including the amount of salt tablets, fluid restriction, and diuretics was collected. We compared hyponatremic patients with those who received salt tablets versus those who did not receive salt tablets. The primary outcome of interest was the change in serum sodium at 48 hours between the two groups. Results A total of 1258 medical records were initially screened with inclusion and exclusion criteria. After screening, there were 83 patients included in the study. Forty-two patients received salt tablets and 41 patients were in the group that did not receive salt tablets. Patients treated with salt tablets were older, more often female, and had lower body weight and lower initial serum sodium. The change in serum sodium after 48 hours was higher in the salt tablet group (5.2 mEq/L) than the non-salt tablet group (3.1 mEq/L; P < 0.001). This difference in serum sodium between the two groups remained statistically significant when adjusted for age, sex, weight, and initial serum sodium. Conclusions The use of salt tablets in the treatment of euvolemic hyponatremia is associated with a small but significant improvement in serum sodium compared with patients who did not receive such therapy, even after adjusting for age, sex, weight, and initial serum sodium. This study supports the effectiveness of salt tablets in the treatment of euvolemic hyponatremia in medical patients.
引用
收藏
页码:125 / 129
页数:5
相关论文
共 50 条
  • [41] The treatment of severe hyponatremia
    Gross, P
    Reimann, D
    Neidel, J
    Döke, C
    Prospert, F
    Decaux, G
    Verbalis, J
    Schrier, RW
    [J]. KIDNEY INTERNATIONAL, 1998, : S6 - S11
  • [42] Treatment of Severe Hyponatremia
    Sterns, Richard H.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (04): : 641 - 649
  • [43] Urea for the Treatment of Hyponatremia
    Rondon-Berrios, Helbert
    Tandukar, Srijan
    Mor, Maria K.
    Ray, Evan C.
    Bender, Filitsa H.
    Kleyman, Thomas R.
    Weisbord, Steven D.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (11): : 1627 - 1632
  • [44] Pathogenesis, clinical diagnosis and treatment of hyponatremia in hepatorenal syndrome
    Liu, Lin
    Tang, Shanhong
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 38 - 38
  • [45] Hyponatremia secondary to transient renal salt wasting (TRSW): A not so uncommon observation in the elderly
    Musch, Wim
    Decaux, Guy
    [J]. CLINICAL NEPHROLOGY, 2019, 91 (06) : 344 - 352
  • [46] Cerebral Salt Wasting Is a Real Cause of Hyponatremia: COMMENTARY
    Palmer, Biff F.
    Clegg, Deborah J.
    [J]. KIDNEY360, 2023, 4 (04): : E445 - E447
  • [47] Pathogenesis, clinical diagnosis and treatment of hyponatremia in hepatorenal syndrome
    Liu, Lin
    Tang, Shanhong
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 38 - 38
  • [48] Cerebral Salt Wasting Is a Real Cause of Hyponatremia: CON
    Sterns, Richard H.
    Rondon-Berrios, Helbert
    [J]. KIDNEY360, 2023, 4 (04): : E441 - E444
  • [49] Cerebral Salt Wasting Is a Real Cause of Hyponatremia: PRO
    Maesaka, John K.
    Imbriano, Louis J.
    [J]. KIDNEY360, 2023, 4 (04): : E437 - E440
  • [50] Efficacy and Safety of Oral Conivaptan, a Vasopressin-Receptor Antagonist, Evaluated in a Randomized, Controlled Trial in Patients With Euvolemic or Hypervolemic Hyponatremia
    Annane, Djillali
    Decaux, Guy
    Smith, Neila
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2009, 337 (01) : 28 - 36